These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15312366)
1. [Correlation of E2F-1 and Rb expression with papillomatosis and ductal carcinoma in situ of the breast]. Niu Y; Li Y; Niu RF; Lü AJ; Fu XL Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):290-3. PubMed ID: 15312366 [TBL] [Abstract][Full Text] [Related]
2. [The clinical significance of the expression of four cell cycle regulators in breast papillomotosis]. Niu Y; Liu TJ; Li Y; Yu Y; Lü AJ; Fu XL Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1769-73. PubMed ID: 14642081 [TBL] [Abstract][Full Text] [Related]
3. E2F-1: a proliferative marker of breast neoplasia. Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484 [TBL] [Abstract][Full Text] [Related]
4. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells. Davis JN; McCabe MT; Hayward SW; Park JM; Day ML Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358 [TBL] [Abstract][Full Text] [Related]
5. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497 [TBL] [Abstract][Full Text] [Related]
6. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations. García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179 [TBL] [Abstract][Full Text] [Related]
7. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
8. Rb/E2F: a two-edged sword in the melanocytic system. Halaban R Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142 [TBL] [Abstract][Full Text] [Related]
9. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells. Tomari K; Kumagai T; Shimizu T; Takeda K Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway. Young AP; Nagarajan R; Longmore GD Oncogene; 2003 Oct; 22(46):7209-17. PubMed ID: 14562049 [TBL] [Abstract][Full Text] [Related]
12. [Expression of pRb and E2F-1 and telomerase activity in ameloblastoma]. Zhong M; Wang J; Zhang B; Hou L; Yue YL; Li ZJ Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):406-9. PubMed ID: 15498350 [TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53]. Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603 [TBL] [Abstract][Full Text] [Related]
14. E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line. Wong CF; Barnes LM; Dahler AL; Smith L; Popa C; Serewko-Auret MM; Saunders NA Oncogene; 2005 May; 24(21):3525-34. PubMed ID: 15735752 [TBL] [Abstract][Full Text] [Related]
15. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. McCabe MT; Davis JN; Day ML Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357 [TBL] [Abstract][Full Text] [Related]
16. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer. Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB Clin Cancer Res; 2007 Jan; 13(2 Pt 1):467-74. PubMed ID: 17255267 [TBL] [Abstract][Full Text] [Related]
17. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Rubin SM; Gall AL; Zheng N; Pavletich NP Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038 [TBL] [Abstract][Full Text] [Related]
18. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus. Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868 [TBL] [Abstract][Full Text] [Related]
19. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs). Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954 [TBL] [Abstract][Full Text] [Related]
20. Concordant loss of fragile gene expression early in breast cancer development. Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]